
Hims & Hers Health Inc. (NYSE:HIMS) launched a new category in men’s health on Wednesday, offering access to affordable and personalized treatment plans for low testosterone.
An estimated 20 million men in the U.S. struggle with low testosterone.

Hims & Hers Health Inc. (NYSE:HIMS) launched a new category in men’s health on Wednesday, offering access to affordable and personalized treatment plans for low testosterone.
An estimated 20 million men in the U.S. struggle with low testosterone.